Two spin-offs of the University of Barcelona will participate in Spin 2016

Two spin-offs of the University of Barcelona will participate in Spin 2016, the meeting point of Latin American university entrepreneurship that will be held in Santiago de Compostela.

NeuroTransvirtual Technologies (NTV-Tech), a spin-off of ...



The FBG will attend Biospain during the Biotechnology Week

From 28 to 30 September, the FBG will visit the Biospain fair with the threefold objective of promoting UB technologies available for licensing, presenting the different capabilities of UB research groups, and seeking investors for various spin-offs in...



The FBG receives € 150,000 from the AECC for childhood cancer research

The project on neuroblastoma led by Elisa Martí Gorostiza, a researcher at the Institute of Molecular Biology of Barcelona-CSIC and the Catalan Biotechnology Reference Network (XRB), has received one of the three grants for research projects on ...



The University of Barcelona opens a new line of funding to promote the innovation and transfer activities carried out by its researchers

The University of Barcelona has created the Fund for the Promotion of Innovation (F2I) through the Bosch i Gimpera Foundation, its office for the transfer of technology and innovation. The Fund is an initiative designed to foster the innovation and tra...



Ruth de Diego: «Without language we would have to redefine ourselves as a species»

Ruth Diego Balaguer wanted to devote herself to sociology until psychobiology's web of brain networks captivated her. Specialized in Cognitive Neuroscience, this ICREA researcher is leading the research group ‘Brain Mechanisms of Language Lea...



Did you know that the testing of drugs for the treatment of Alzheimer's disease requires in vivo models?

The design and testing of drugs potentially useful in the treatment of Alzheimer's disease require models that reproduce the etiopathogenic factors responsible for the disease. The research group “Neuropharmacology: Preventing Ageing,” ...